Investigating how sex differences affect immune responses in viral infections

Sex Differences in NK Cells Mediated by X-linked UTX

NIH-funded research University of California Los Angeles · NIH-10884424

This study is looking at how men and women respond differently to viral infections, especially focusing on a type of immune cell called natural killer (NK) cells, to help figure out why men have more of these cells but produce less of an important immune signal; the goal is to improve treatments for viral infections based on whether someone is male or female.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles NIH-funded
Lab location1 site (Los Angeles, United States)
Project IDNIH-10884424 on NIH RePORTER

What this research studies

This research explores the differences in immune responses to viral infections between males and females, focusing on natural killer (NK) cells, which are crucial for fighting off viruses like human cytomegalovirus (HCMV). The study examines how the X-linked gene UTX influences the number and function of NK cells, particularly looking at why males, despite having more NK cells, produce less of a key immune signaling molecule called IFN-γ. By using both mouse models and human samples, the researchers aim to uncover the underlying mechanisms that contribute to these sex-based differences in immune response. This could lead to a better understanding of how to tailor treatments for viral infections based on sex.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with viral infections, particularly those affected by human cytomegalovirus, and those interested in understanding how sex differences may impact their immune response.

Not a fit: Patients who do not have viral infections or those whose immune responses are not influenced by sex differences may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies for viral infections that take into account sex differences in immune responses.

How similar studies have performed: Previous research has indicated that sex differences in immune responses are significant, suggesting that this approach could yield valuable insights, although the specific focus on UTX in NK cells is relatively novel.

Where this research is happening

Los Angeles, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.